Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Indivior (INDVL)

Add To Portfolio

0.000p

Change Today:

0.000p
52 Week High: 0.000p
52 Week Low: 0.000p

Currency: UK Pounds
Shares Issued: 718.58m
Volume: 0

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

1 Day Chart (24-12-2025)

6 Month Chart

More Indivior charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%
Div Cover	n/a
Op Mrgn	-1.9%
ROCE	n/a

	Latest	F'cast
P/E	n/a
PEG	n/a
Pr/Revenue	n/a
Pr/Book	n/a

	Latest	F'cast
Revenue	8.7%
PBT	n/a
EPS	n/a
DPS	n/a

Indivior Fundamentals

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-20	647.00	(173.00)	40.00¢	3.7	n/a	-67%	n/a	0.0%
31-Dec-21	791.00	190.00	19.20¢	18.1	n/a	-52%	n/a	0.0%
31-Dec-22	901.00	(95.00)	(38.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	1,093.00	1.00	1.00¢	1,606.1	n/a	n/a	n/a	0.0%
31-Dec-24	1,188.00	(43.00)	(36.00)¢	n/a	n/a	n/a	n/a	0.0%